COVID-19 Impact on Global Cell Therapy and Tissue Engineering Market Size, Status and Forecast 2020-2026
This report focuses on the global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Betalin Therapeutics
- BioCardia, Inc
- BioReliance Corporation
- Biosolution Co.
- Brainstorm Cell Therapeutics, Inc
- MaxCyte, Inc
- Medigene AG
- MEDIPOST CO.
- Mesoblast Limited
- Miromatrix Medical, Inc.
- MolMed S.p.A
- Mustang Bio, Inc
- NantKwest, Inc.
- Neuralstem, Inc
- NexImmune, Inc.
- Nohla Therapeutics, Inc
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
- Rubius Therapeutics, Inc.
- Sangamo Therapeutics, Inc
- Voyager Therapeutics, Inc
- Waisman Biomanufacturing
- WindMIL Therapeutics, Inc.
- Wuxi App Tec, Inc.
- ReNeuron Group plc
- Richter-Helm BioLogics GmbH & Co. KG
- RoosterBio, Inc
- RoslinCT
- Cell Therapy
- Tissue Engineering
- Cell Defects
- Genetic Diseases
- Neurodegenerative Diseases
- Tissue Malignancies
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Cell Therapy and Tissue Engineering status, future forecast, growth opportunity, key market and key players.
- To present the Cell Therapy and Tissue Engineering development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
1.4 Market Analysis by Type
1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.5 Market by Application
1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026
1.5.2 Cell Defects
1.5.3 Genetic Diseases
1.5.4 Neurodegenerative Diseases
1.5.5 Tissue Malignancies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cell Therapy and Tissue Engineering Industry Impact
1.6.1 How the Covid-19 is Affecting the Cell Therapy and Tissue Engineering Industry
1.6.1.1 Cell Therapy and Tissue Engineering Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cell Therapy and Tissue Engineering Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cell Therapy and Tissue Engineering Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cell Therapy and Tissue Engineering Market Perspective (2015-2026)
2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2015-2020)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cell Therapy and Tissue Engineering Market Growth Strategy
2.3.6 Primary Interviews with Key Cell Therapy and Tissue Engineering Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy and Tissue Engineering Players by Market Size
3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2015-2020)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2015-2020)
3.1.3 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.2.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2019
3.3 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
3.4 Key Players Cell Therapy and Tissue Engineering Product Solution and Service
3.5 Date of Enter into Cell Therapy and Tissue Engineering Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2015-2020)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2021-2026)
5 CELL THERAPY AND TISSUE ENGINEERING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cell Therapy and Tissue Engineering Market Size (2015-2020)
6.2 Cell Therapy and Tissue Engineering Key Players in North America (2019-2020)
6.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2015-2020)
7.2 Cell Therapy and Tissue Engineering Key Players in Europe (2019-2020)
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
8 CHINA
8.1 China Cell Therapy and Tissue Engineering Market Size (2015-2020)
8.2 Cell Therapy and Tissue Engineering Key Players in China (2019-2020)
8.3 China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
8.4 China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cell Therapy and Tissue Engineering Market Size (2015-2020)
9.2 Cell Therapy and Tissue Engineering Key Players in Japan (2019-2020)
9.3 Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
9.4 Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2015-2020)
10.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
10.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
11 INDIA
11.1 India Cell Therapy and Tissue Engineering Market Size (2015-2020)
11.2 Cell Therapy and Tissue Engineering Key Players in India (2019-2020)
11.3 India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
11.4 India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2015-2020)
12.2 Cell Therapy and Tissue Engineering Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
12.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Betalin Therapeutics
13.1.1 Betalin Therapeutics Company Details
13.1.2 Betalin Therapeutics Business Overview and Its Total Revenue
13.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
13.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020))
13.1.5 Betalin Therapeutics Recent Development
13.2 BioCardia, Inc
13.2.1 BioCardia, Inc Company Details
13.2.2 BioCardia, Inc Business Overview and Its Total Revenue
13.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
13.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.2.5 BioCardia, Inc Recent Development
13.3 BioReliance Corporation
13.3.1 BioReliance Corporation Company Details
13.3.2 BioReliance Corporation Business Overview and Its Total Revenue
13.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
13.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.3.5 BioReliance Corporation Recent Development
13.4 Biosolution Co.
13.4.1 Biosolution Co. Company Details
13.4.2 Biosolution Co. Business Overview and Its Total Revenue
13.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
13.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.4.5 Biosolution Co. Recent Development
13.5 Brainstorm Cell Therapeutics, Inc
13.5.1 Brainstorm Cell Therapeutics, Inc Company Details
13.5.2 Brainstorm Cell Therapeutics, Inc Business Overview and Its Total Revenue
13.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
13.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
13.6 MaxCyte, Inc
13.6.1 MaxCyte, Inc Company Details
13.6.2 MaxCyte, Inc Business Overview and Its Total Revenue
13.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
13.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.6.5 MaxCyte, Inc Recent Development
13.7 Medigene AG
13.7.1 Medigene AG Company Details
13.7.2 Medigene AG Business Overview and Its Total Revenue
13.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
13.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.7.5 Medigene AG Recent Development
13.8 MEDIPOST CO.
13.8.1 MEDIPOST CO. Company Details
13.8.2 MEDIPOST CO. Business Overview and Its Total Revenue
13.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
13.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.8.5 MEDIPOST CO. Recent Development
13.9 Mesoblast Limited
13.9.1 Mesoblast Limited Company Details
13.9.2 Mesoblast Limited Business Overview and Its Total Revenue
13.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
13.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.9.5 Mesoblast Limited Recent Development
13.10 Miromatrix Medical, Inc.
13.10.1 Miromatrix Medical, Inc. Company Details
13.10.2 Miromatrix Medical, Inc. Business Overview and Its Total Revenue
13.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
13.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.10.5 Miromatrix Medical, Inc. Recent Development
13.11 MolMed S.p.A
10.11.1 MolMed S.p.A Company Details
10.11.2 MolMed S.p.A Business Overview and Its Total Revenue
10.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
10.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.11.5 MolMed S.p.A Recent Development
13.12 Mustang Bio, Inc
10.12.1 Mustang Bio, Inc Company Details
10.12.2 Mustang Bio, Inc Business Overview and Its Total Revenue
10.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
10.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.12.5 Mustang Bio, Inc Recent Development
13.13 NantKwest, Inc.
10.13.1 NantKwest, Inc. Company Details
10.13.2 NantKwest, Inc. Business Overview and Its Total Revenue
10.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
10.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.13.5 NantKwest, Inc. Recent Development
13.14 Neuralstem, Inc
10.14.1 Neuralstem, Inc Company Details
10.14.2 Neuralstem, Inc Business Overview and Its Total Revenue
10.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
10.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.14.5 Neuralstem, Inc Recent Development
13.15 NexImmune, Inc.
10.15.1 NexImmune, Inc. Company Details
10.15.2 NexImmune, Inc. Business Overview and Its Total Revenue
10.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
10.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.15.5 NexImmune, Inc. Recent Development
13.16 Nohla Therapeutics, Inc
10.16.1 Nohla Therapeutics, Inc Company Details
10.16.2 Nohla Therapeutics, Inc Business Overview and Its Total Revenue
10.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.16.5 Nohla Therapeutics, Inc Recent Development
13.17 ReNeuron Group plc
10.17.1 ReNeuron Group plc Company Details
10.17.2 ReNeuron Group plc Business Overview and Its Total Revenue
10.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
10.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.17.5 ReNeuron Group plc Recent Development
13.18 Richter-Helm BioLogics GmbH & Co. KG
10.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
10.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
10.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
10.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
13.19 RoosterBio, Inc
10.19.1 RoosterBio, Inc Company Details
10.19.2 RoosterBio, Inc Business Overview and Its Total Revenue
10.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
10.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.19.5 RoosterBio, Inc Recent Development
13.20 RoslinCT
10.20.1 RoslinCT Company Details
10.20.2 RoslinCT Business Overview and Its Total Revenue
10.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
10.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.20.5 RoslinCT Recent Development
13.21 Rubius Therapeutics, Inc.
10.21.1 Rubius Therapeutics, Inc. Company Details
10.21.2 Rubius Therapeutics, Inc. Business Overview and Its Total Revenue
10.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
10.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.21.5 Rubius Therapeutics, Inc. Recent Development
13.22 Sangamo Therapeutics, Inc
10.22.1 Sangamo Therapeutics, Inc Company Details
10.22.2 Sangamo Therapeutics, Inc Business Overview and Its Total Revenue
10.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.22.5 Sangamo Therapeutics, Inc Recent Development
13.23 Voyager Therapeutics, Inc
10.23.1 Voyager Therapeutics, Inc Company Details
10.23.2 Voyager Therapeutics, Inc Business Overview and Its Total Revenue
10.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.23.5 Voyager Therapeutics, Inc Recent Development
13.24 Waisman Biomanufacturing
10.24.1 Waisman Biomanufacturing Company Details
10.24.2 Waisman Biomanufacturing Business Overview and Its Total Revenue
10.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
10.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.24.5 Waisman Biomanufacturing Recent Development
13.25 WindMIL Therapeutics, Inc.
10.25.1 WindMIL Therapeutics, Inc. Company Details
10.25.2 WindMIL Therapeutics, Inc. Business Overview and Its Total Revenue
10.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
10.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.25.5 WindMIL Therapeutics, Inc. Recent Development
13.26 Wuxi App Tec, Inc.
10.26.1 Wuxi App Tec, Inc. Company Details
10.26.2 Wuxi App Tec, Inc. Business Overview and Its Total Revenue
10.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
10.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.26.5 Wuxi App Tec, Inc. Recent Development
13.27 ReNeuron Group plc
10.27.1 ReNeuron Group plc Company Details
10.27.2 ReNeuron Group plc Business Overview and Its Total Revenue
10.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
10.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.27.5 ReNeuron Group plc Recent Development
13.28 Richter-Helm BioLogics GmbH & Co. KG
10.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
10.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
10.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
10.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
13.29 RoosterBio, Inc
10.29.1 RoosterBio, Inc Company Details
10.29.2 RoosterBio, Inc Business Overview and Its Total Revenue
10.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
10.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.29.5 RoosterBio, Inc Recent Development
13.30 RoslinCT
10.30.1 RoslinCT Company Details
10.30.2 RoslinCT Business Overview and Its Total Revenue
10.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
10.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.30.5 RoslinCT Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
1.4 Market Analysis by Type
1.4.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.5 Market by Application
1.5.1 Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026
1.5.2 Cell Defects
1.5.3 Genetic Diseases
1.5.4 Neurodegenerative Diseases
1.5.5 Tissue Malignancies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Cell Therapy and Tissue Engineering Industry Impact
1.6.1 How the Covid-19 is Affecting the Cell Therapy and Tissue Engineering Industry
1.6.1.1 Cell Therapy and Tissue Engineering Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cell Therapy and Tissue Engineering Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cell Therapy and Tissue Engineering Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cell Therapy and Tissue Engineering Market Perspective (2015-2026)
2.2 Cell Therapy and Tissue Engineering Growth Trends by Regions
2.2.1 Cell Therapy and Tissue Engineering Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cell Therapy and Tissue Engineering Historic Market Share by Regions (2015-2020)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cell Therapy and Tissue Engineering Market Growth Strategy
2.3.6 Primary Interviews with Key Cell Therapy and Tissue Engineering Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy and Tissue Engineering Players by Market Size
3.1.1 Global Top Cell Therapy and Tissue Engineering Players by Revenue (2015-2020)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2015-2020)
3.1.3 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.2.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2019
3.3 Cell Therapy and Tissue Engineering Key Players Head office and Area Served
3.4 Key Players Cell Therapy and Tissue Engineering Product Solution and Service
3.5 Date of Enter into Cell Therapy and Tissue Engineering Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2015-2020)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2021-2026)
5 CELL THERAPY AND TISSUE ENGINEERING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cell Therapy and Tissue Engineering Market Size (2015-2020)
6.2 Cell Therapy and Tissue Engineering Key Players in North America (2019-2020)
6.3 North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2015-2020)
7.2 Cell Therapy and Tissue Engineering Key Players in Europe (2019-2020)
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
8 CHINA
8.1 China Cell Therapy and Tissue Engineering Market Size (2015-2020)
8.2 Cell Therapy and Tissue Engineering Key Players in China (2019-2020)
8.3 China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
8.4 China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cell Therapy and Tissue Engineering Market Size (2015-2020)
9.2 Cell Therapy and Tissue Engineering Key Players in Japan (2019-2020)
9.3 Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
9.4 Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cell Therapy and Tissue Engineering Market Size (2015-2020)
10.2 Cell Therapy and Tissue Engineering Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
10.4 Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
11 INDIA
11.1 India Cell Therapy and Tissue Engineering Market Size (2015-2020)
11.2 Cell Therapy and Tissue Engineering Key Players in India (2019-2020)
11.3 India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
11.4 India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cell Therapy and Tissue Engineering Market Size (2015-2020)
12.2 Cell Therapy and Tissue Engineering Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020)
12.4 Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Betalin Therapeutics
13.1.1 Betalin Therapeutics Company Details
13.1.2 Betalin Therapeutics Business Overview and Its Total Revenue
13.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
13.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020))
13.1.5 Betalin Therapeutics Recent Development
13.2 BioCardia, Inc
13.2.1 BioCardia, Inc Company Details
13.2.2 BioCardia, Inc Business Overview and Its Total Revenue
13.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
13.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.2.5 BioCardia, Inc Recent Development
13.3 BioReliance Corporation
13.3.1 BioReliance Corporation Company Details
13.3.2 BioReliance Corporation Business Overview and Its Total Revenue
13.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
13.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.3.5 BioReliance Corporation Recent Development
13.4 Biosolution Co.
13.4.1 Biosolution Co. Company Details
13.4.2 Biosolution Co. Business Overview and Its Total Revenue
13.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
13.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.4.5 Biosolution Co. Recent Development
13.5 Brainstorm Cell Therapeutics, Inc
13.5.1 Brainstorm Cell Therapeutics, Inc Company Details
13.5.2 Brainstorm Cell Therapeutics, Inc Business Overview and Its Total Revenue
13.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
13.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.5.5 Brainstorm Cell Therapeutics, Inc Recent Development
13.6 MaxCyte, Inc
13.6.1 MaxCyte, Inc Company Details
13.6.2 MaxCyte, Inc Business Overview and Its Total Revenue
13.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
13.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.6.5 MaxCyte, Inc Recent Development
13.7 Medigene AG
13.7.1 Medigene AG Company Details
13.7.2 Medigene AG Business Overview and Its Total Revenue
13.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
13.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.7.5 Medigene AG Recent Development
13.8 MEDIPOST CO.
13.8.1 MEDIPOST CO. Company Details
13.8.2 MEDIPOST CO. Business Overview and Its Total Revenue
13.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
13.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.8.5 MEDIPOST CO. Recent Development
13.9 Mesoblast Limited
13.9.1 Mesoblast Limited Company Details
13.9.2 Mesoblast Limited Business Overview and Its Total Revenue
13.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
13.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.9.5 Mesoblast Limited Recent Development
13.10 Miromatrix Medical, Inc.
13.10.1 Miromatrix Medical, Inc. Company Details
13.10.2 Miromatrix Medical, Inc. Business Overview and Its Total Revenue
13.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
13.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
13.10.5 Miromatrix Medical, Inc. Recent Development
13.11 MolMed S.p.A
10.11.1 MolMed S.p.A Company Details
10.11.2 MolMed S.p.A Business Overview and Its Total Revenue
10.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
10.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.11.5 MolMed S.p.A Recent Development
13.12 Mustang Bio, Inc
10.12.1 Mustang Bio, Inc Company Details
10.12.2 Mustang Bio, Inc Business Overview and Its Total Revenue
10.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
10.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.12.5 Mustang Bio, Inc Recent Development
13.13 NantKwest, Inc.
10.13.1 NantKwest, Inc. Company Details
10.13.2 NantKwest, Inc. Business Overview and Its Total Revenue
10.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
10.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.13.5 NantKwest, Inc. Recent Development
13.14 Neuralstem, Inc
10.14.1 Neuralstem, Inc Company Details
10.14.2 Neuralstem, Inc Business Overview and Its Total Revenue
10.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
10.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.14.5 Neuralstem, Inc Recent Development
13.15 NexImmune, Inc.
10.15.1 NexImmune, Inc. Company Details
10.15.2 NexImmune, Inc. Business Overview and Its Total Revenue
10.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
10.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.15.5 NexImmune, Inc. Recent Development
13.16 Nohla Therapeutics, Inc
10.16.1 Nohla Therapeutics, Inc Company Details
10.16.2 Nohla Therapeutics, Inc Business Overview and Its Total Revenue
10.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.16.5 Nohla Therapeutics, Inc Recent Development
13.17 ReNeuron Group plc
10.17.1 ReNeuron Group plc Company Details
10.17.2 ReNeuron Group plc Business Overview and Its Total Revenue
10.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
10.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.17.5 ReNeuron Group plc Recent Development
13.18 Richter-Helm BioLogics GmbH & Co. KG
10.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
10.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
10.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
10.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
13.19 RoosterBio, Inc
10.19.1 RoosterBio, Inc Company Details
10.19.2 RoosterBio, Inc Business Overview and Its Total Revenue
10.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
10.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.19.5 RoosterBio, Inc Recent Development
13.20 RoslinCT
10.20.1 RoslinCT Company Details
10.20.2 RoslinCT Business Overview and Its Total Revenue
10.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
10.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.20.5 RoslinCT Recent Development
13.21 Rubius Therapeutics, Inc.
10.21.1 Rubius Therapeutics, Inc. Company Details
10.21.2 Rubius Therapeutics, Inc. Business Overview and Its Total Revenue
10.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
10.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.21.5 Rubius Therapeutics, Inc. Recent Development
13.22 Sangamo Therapeutics, Inc
10.22.1 Sangamo Therapeutics, Inc Company Details
10.22.2 Sangamo Therapeutics, Inc Business Overview and Its Total Revenue
10.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.22.5 Sangamo Therapeutics, Inc Recent Development
13.23 Voyager Therapeutics, Inc
10.23.1 Voyager Therapeutics, Inc Company Details
10.23.2 Voyager Therapeutics, Inc Business Overview and Its Total Revenue
10.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
10.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.23.5 Voyager Therapeutics, Inc Recent Development
13.24 Waisman Biomanufacturing
10.24.1 Waisman Biomanufacturing Company Details
10.24.2 Waisman Biomanufacturing Business Overview and Its Total Revenue
10.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
10.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.24.5 Waisman Biomanufacturing Recent Development
13.25 WindMIL Therapeutics, Inc.
10.25.1 WindMIL Therapeutics, Inc. Company Details
10.25.2 WindMIL Therapeutics, Inc. Business Overview and Its Total Revenue
10.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
10.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.25.5 WindMIL Therapeutics, Inc. Recent Development
13.26 Wuxi App Tec, Inc.
10.26.1 Wuxi App Tec, Inc. Company Details
10.26.2 Wuxi App Tec, Inc. Business Overview and Its Total Revenue
10.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
10.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.26.5 Wuxi App Tec, Inc. Recent Development
13.27 ReNeuron Group plc
10.27.1 ReNeuron Group plc Company Details
10.27.2 ReNeuron Group plc Business Overview and Its Total Revenue
10.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
10.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.27.5 ReNeuron Group plc Recent Development
13.28 Richter-Helm BioLogics GmbH & Co. KG
10.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
10.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview and Its Total Revenue
10.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
10.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Development
13.29 RoosterBio, Inc
10.29.1 RoosterBio, Inc Company Details
10.29.2 RoosterBio, Inc Business Overview and Its Total Revenue
10.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
10.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.29.5 RoosterBio, Inc Recent Development
13.30 RoslinCT
10.30.1 RoslinCT Company Details
10.30.2 RoslinCT Business Overview and Its Total Revenue
10.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
10.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020)
10.30.5 RoslinCT Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Cell Therapy and Tissue Engineering Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
Table 3. Ranking of Global Top Cell Therapy and Tissue Engineering Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. COVID-19 Impact Global Market: (Four Cell Therapy and Tissue Engineering Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Cell Therapy and Tissue Engineering Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Cell Therapy and Tissue Engineering Players to Combat Covid-19 Impact
Table 12. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Cell Therapy and Tissue Engineering Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Cell Therapy and Tissue Engineering Market Share by Regions (2015-2020)
Table 16. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Cell Therapy and Tissue Engineering Market Growth Strategy
Table 22. Main Points Interviewed from Key Cell Therapy and Tissue Engineering Players
Table 23. Global Cell Therapy and Tissue Engineering Revenue by Players (2015-2020) (Million US$)
Table 24. Global Cell Therapy and Tissue Engineering Market Share by Players (2015-2020)
Table 25. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019)
Table 26. Global Cell Therapy and Tissue Engineering by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cell Therapy and Tissue Engineering Product Solution and Service
Table 29. Date of Enter into Cell Therapy and Tissue Engineering Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 32. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2015-2020)
Table 33. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2021-2026)
Table 34. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2015-2020)
Table 35. Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 36. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2021-2026)
Table 37. North America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 39. North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 40. North America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 41. North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 42. North America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 43. Europe Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 45. Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 47. Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 49. China Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 50. China Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 51. China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 52. China Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 53. China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 54. China Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 55. Japan Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 57. Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 59. Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 63. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 65. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 67. India Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 68. India Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 69. India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 70. India Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 71. India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 72. India Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 75. Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 77. Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 79. Betalin Therapeutics Company Details
Table 80. Betalin Therapeutics Business Overview
Table 81. Betalin Therapeutics Product
Table 82. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 83. Betalin Therapeutics Recent Development
Table 84. BioCardia, Inc Company Details
Table 85. BioCardia, Inc Business Overview
Table 86. BioCardia, Inc Product
Table 87. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 88. BioCardia, Inc Recent Development
Table 89. BioReliance Corporation Company Details
Table 90. BioReliance Corporation Business Overview
Table 91. BioReliance Corporation Product
Table 92. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 93. BioReliance Corporation Recent Development
Table 94. Biosolution Co. Company Details
Table 95. Biosolution Co. Business Overview
Table 96. Biosolution Co. Product
Table 97. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 98. Biosolution Co. Recent Development
Table 99. Brainstorm Cell Therapeutics, Inc Company Details
Table 100. Brainstorm Cell Therapeutics, Inc Business Overview
Table 101. Brainstorm Cell Therapeutics, Inc Product
Table 102. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 103. Brainstorm Cell Therapeutics, Inc Recent Development
Table 104. MaxCyte, Inc Company Details
Table 105. MaxCyte, Inc Business Overview
Table 106. MaxCyte, Inc Product
Table 107. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 108. MaxCyte, Inc Recent Development
Table 109. Medigene AG Company Details
Table 110. Medigene AG Business Overview
Table 111. Medigene AG Product
Table 112. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 113. Medigene AG Recent Development
Table 114. MEDIPOST CO. Business Overview
Table 115. MEDIPOST CO. Product
Table 116. MEDIPOST CO. Company Details
Table 117. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 118. MEDIPOST CO. Recent Development
Table 119. Mesoblast Limited Company Details
Table 120. Mesoblast Limited Business Overview
Table 121. Mesoblast Limited Product
Table 122. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 123. Mesoblast Limited Recent Development
Table 124. Miromatrix Medical, Inc. Company Details
Table 125. Miromatrix Medical, Inc. Business Overview
Table 126. Miromatrix Medical, Inc. Product
Table 127. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 128. Miromatrix Medical, Inc. Recent Development
Table 129. MolMed S.p.A Company Details
Table 130. MolMed S.p.A Business Overview
Table 131. MolMed S.p.A Product
Table 132. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 133. MolMed S.p.A Recent Development
Table 134. Mustang Bio, Inc Company Details
Table 135. Mustang Bio, Inc Business Overview
Table 136. Mustang Bio, Inc Product
Table 137. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 138. Mustang Bio, Inc Recent Development
Table 139. NantKwest, Inc. Company Details
Table 140. NantKwest, Inc. Business Overview
Table 141. NantKwest, Inc. Product
Table 142. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 143. NantKwest, Inc. Recent Development
Table 144. Neuralstem, Inc Company Details
Table 145. Neuralstem, Inc Business Overview
Table 146. Neuralstem, Inc Product
Table 147. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 148. Neuralstem, Inc Recent Development
Table 149. NexImmune, Inc. Company Details
Table 150. NexImmune, Inc. Business Overview
Table 151. NexImmune, Inc. Product
Table 152. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 153. NexImmune, Inc. Recent Development
Table 154. Nohla Therapeutics, Inc Company Details
Table 155. Nohla Therapeutics, Inc Business Overview
Table 156. Nohla Therapeutics, Inc Product
Table 157. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 158. Nohla Therapeutics, Inc Recent Development
Table 159. ReNeuron Group plc Company Details
Table 160. ReNeuron Group plc Business Overview
Table 161. ReNeuron Group plc Product
Table 162. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 163. ReNeuron Group plc Recent Development
Table 164. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 165. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 166. Richter-Helm BioLogics GmbH & Co. KG Product
Table 167. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 168. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 169. RoosterBio, Inc Company Details
Table 170. RoosterBio, Inc Business Overview
Table 171. RoosterBio, Inc Product
Table 172. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 173. RoosterBio, Inc Recent Development
Table 174. RoslinCT Company Details
Table 175. RoslinCT Business Overview
Table 176. RoslinCT Product
Table 177. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 178. RoslinCT Recent Development
Table 179. Rubius Therapeutics, Inc. Company Details
Table 180. Rubius Therapeutics, Inc. Business Overview
Table 181. Rubius Therapeutics, Inc. Product
Table 182. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 183. Rubius Therapeutics, Inc. Recent Development
Table 184. Sangamo Therapeutics, Inc Company Details
Table 185. Sangamo Therapeutics, Inc Business Overview
Table 186. Sangamo Therapeutics, Inc Product
Table 187. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 188. Sangamo Therapeutics, Inc Recent Development
Table 189. Voyager Therapeutics, Inc Company Details
Table 190. Voyager Therapeutics, Inc Business Overview
Table 191. Voyager Therapeutics, Inc Product
Table 192. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 193. Voyager Therapeutics, Inc Recent Development
Table 194. Waisman Biomanufacturing Company Details
Table 195. Waisman Biomanufacturing Business Overview
Table 196. Waisman Biomanufacturing Product
Table 197. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 198. Waisman Biomanufacturing Recent Development
Table 199. WindMIL Therapeutics, Inc. Company Details
Table 200. WindMIL Therapeutics, Inc. Business Overview
Table 201. WindMIL Therapeutics, Inc. Product
Table 202. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 203. WindMIL Therapeutics, Inc. Recent Development
Table 204. Wuxi App Tec, Inc. Company Details
Table 205. Wuxi App Tec, Inc. Business Overview
Table 206. Wuxi App Tec, Inc. Product
Table 207. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 208. Wuxi App Tec, Inc. Recent Development
Table 209. ReNeuron Group plc Company Details
Table 210. ReNeuron Group plc Business Overview
Table 211. ReNeuron Group plc Product
Table 212. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 213. ReNeuron Group plc Recent Development
Table 214. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 215. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 216. Richter-Helm BioLogics GmbH & Co. KG Product
Table 217. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 218. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 219. RoosterBio, Inc Company Details
Table 220. RoosterBio, Inc Business Overview
Table 221. RoosterBio, Inc Product
Table 222. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 223. RoosterBio, Inc Recent Development
Table 224. RoslinCT Company Details
Table 225. RoslinCT Business Overview
Table 226. RoslinCT Product
Table 227. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 228. RoslinCT Recent Development
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
Table 1. Cell Therapy and Tissue Engineering Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Therapy and Tissue Engineering Revenue
Table 3. Ranking of Global Top Cell Therapy and Tissue Engineering Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. COVID-19 Impact Global Market: (Four Cell Therapy and Tissue Engineering Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Cell Therapy and Tissue Engineering Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Cell Therapy and Tissue Engineering Players to Combat Covid-19 Impact
Table 12. Global Cell Therapy and Tissue Engineering Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Cell Therapy and Tissue Engineering Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Cell Therapy and Tissue Engineering Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Cell Therapy and Tissue Engineering Market Share by Regions (2015-2020)
Table 16. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Cell Therapy and Tissue Engineering Market Growth Strategy
Table 22. Main Points Interviewed from Key Cell Therapy and Tissue Engineering Players
Table 23. Global Cell Therapy and Tissue Engineering Revenue by Players (2015-2020) (Million US$)
Table 24. Global Cell Therapy and Tissue Engineering Market Share by Players (2015-2020)
Table 25. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019)
Table 26. Global Cell Therapy and Tissue Engineering by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Cell Therapy and Tissue Engineering Product Solution and Service
Table 29. Date of Enter into Cell Therapy and Tissue Engineering Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 32. Global Cell Therapy and Tissue Engineering Market Size Share by Type (2015-2020)
Table 33. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2021-2026)
Table 34. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2015-2020)
Table 35. Global Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 36. Global Cell Therapy and Tissue Engineering Market Size Share by Application (2021-2026)
Table 37. North America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 39. North America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 40. North America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 41. North America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 42. North America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 43. Europe Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 45. Europe Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 47. Europe Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 49. China Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 50. China Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 51. China Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 52. China Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 53. China Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 54. China Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 55. Japan Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 57. Japan Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 59. Japan Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 63. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 65. Southeast Asia Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 67. India Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 68. India Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 69. India Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 70. India Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 71. India Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 72. India Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Cell Therapy and Tissue Engineering Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Cell Therapy and Tissue Engineering Market Share (2019-2020)
Table 75. Central & South America Cell Therapy and Tissue Engineering Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Cell Therapy and Tissue Engineering Market Share by Type (2015-2020)
Table 77. Central & South America Cell Therapy and Tissue Engineering Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Cell Therapy and Tissue Engineering Market Share by Application (2015-2020)
Table 79. Betalin Therapeutics Company Details
Table 80. Betalin Therapeutics Business Overview
Table 81. Betalin Therapeutics Product
Table 82. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 83. Betalin Therapeutics Recent Development
Table 84. BioCardia, Inc Company Details
Table 85. BioCardia, Inc Business Overview
Table 86. BioCardia, Inc Product
Table 87. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 88. BioCardia, Inc Recent Development
Table 89. BioReliance Corporation Company Details
Table 90. BioReliance Corporation Business Overview
Table 91. BioReliance Corporation Product
Table 92. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 93. BioReliance Corporation Recent Development
Table 94. Biosolution Co. Company Details
Table 95. Biosolution Co. Business Overview
Table 96. Biosolution Co. Product
Table 97. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 98. Biosolution Co. Recent Development
Table 99. Brainstorm Cell Therapeutics, Inc Company Details
Table 100. Brainstorm Cell Therapeutics, Inc Business Overview
Table 101. Brainstorm Cell Therapeutics, Inc Product
Table 102. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 103. Brainstorm Cell Therapeutics, Inc Recent Development
Table 104. MaxCyte, Inc Company Details
Table 105. MaxCyte, Inc Business Overview
Table 106. MaxCyte, Inc Product
Table 107. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 108. MaxCyte, Inc Recent Development
Table 109. Medigene AG Company Details
Table 110. Medigene AG Business Overview
Table 111. Medigene AG Product
Table 112. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 113. Medigene AG Recent Development
Table 114. MEDIPOST CO. Business Overview
Table 115. MEDIPOST CO. Product
Table 116. MEDIPOST CO. Company Details
Table 117. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 118. MEDIPOST CO. Recent Development
Table 119. Mesoblast Limited Company Details
Table 120. Mesoblast Limited Business Overview
Table 121. Mesoblast Limited Product
Table 122. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 123. Mesoblast Limited Recent Development
Table 124. Miromatrix Medical, Inc. Company Details
Table 125. Miromatrix Medical, Inc. Business Overview
Table 126. Miromatrix Medical, Inc. Product
Table 127. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 128. Miromatrix Medical, Inc. Recent Development
Table 129. MolMed S.p.A Company Details
Table 130. MolMed S.p.A Business Overview
Table 131. MolMed S.p.A Product
Table 132. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 133. MolMed S.p.A Recent Development
Table 134. Mustang Bio, Inc Company Details
Table 135. Mustang Bio, Inc Business Overview
Table 136. Mustang Bio, Inc Product
Table 137. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 138. Mustang Bio, Inc Recent Development
Table 139. NantKwest, Inc. Company Details
Table 140. NantKwest, Inc. Business Overview
Table 141. NantKwest, Inc. Product
Table 142. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 143. NantKwest, Inc. Recent Development
Table 144. Neuralstem, Inc Company Details
Table 145. Neuralstem, Inc Business Overview
Table 146. Neuralstem, Inc Product
Table 147. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 148. Neuralstem, Inc Recent Development
Table 149. NexImmune, Inc. Company Details
Table 150. NexImmune, Inc. Business Overview
Table 151. NexImmune, Inc. Product
Table 152. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 153. NexImmune, Inc. Recent Development
Table 154. Nohla Therapeutics, Inc Company Details
Table 155. Nohla Therapeutics, Inc Business Overview
Table 156. Nohla Therapeutics, Inc Product
Table 157. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 158. Nohla Therapeutics, Inc Recent Development
Table 159. ReNeuron Group plc Company Details
Table 160. ReNeuron Group plc Business Overview
Table 161. ReNeuron Group plc Product
Table 162. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 163. ReNeuron Group plc Recent Development
Table 164. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 165. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 166. Richter-Helm BioLogics GmbH & Co. KG Product
Table 167. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 168. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 169. RoosterBio, Inc Company Details
Table 170. RoosterBio, Inc Business Overview
Table 171. RoosterBio, Inc Product
Table 172. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 173. RoosterBio, Inc Recent Development
Table 174. RoslinCT Company Details
Table 175. RoslinCT Business Overview
Table 176. RoslinCT Product
Table 177. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 178. RoslinCT Recent Development
Table 179. Rubius Therapeutics, Inc. Company Details
Table 180. Rubius Therapeutics, Inc. Business Overview
Table 181. Rubius Therapeutics, Inc. Product
Table 182. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 183. Rubius Therapeutics, Inc. Recent Development
Table 184. Sangamo Therapeutics, Inc Company Details
Table 185. Sangamo Therapeutics, Inc Business Overview
Table 186. Sangamo Therapeutics, Inc Product
Table 187. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 188. Sangamo Therapeutics, Inc Recent Development
Table 189. Voyager Therapeutics, Inc Company Details
Table 190. Voyager Therapeutics, Inc Business Overview
Table 191. Voyager Therapeutics, Inc Product
Table 192. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 193. Voyager Therapeutics, Inc Recent Development
Table 194. Waisman Biomanufacturing Company Details
Table 195. Waisman Biomanufacturing Business Overview
Table 196. Waisman Biomanufacturing Product
Table 197. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 198. Waisman Biomanufacturing Recent Development
Table 199. WindMIL Therapeutics, Inc. Company Details
Table 200. WindMIL Therapeutics, Inc. Business Overview
Table 201. WindMIL Therapeutics, Inc. Product
Table 202. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 203. WindMIL Therapeutics, Inc. Recent Development
Table 204. Wuxi App Tec, Inc. Company Details
Table 205. Wuxi App Tec, Inc. Business Overview
Table 206. Wuxi App Tec, Inc. Product
Table 207. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 208. Wuxi App Tec, Inc. Recent Development
Table 209. ReNeuron Group plc Company Details
Table 210. ReNeuron Group plc Business Overview
Table 211. ReNeuron Group plc Product
Table 212. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 213. ReNeuron Group plc Recent Development
Table 214. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 215. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 216. Richter-Helm BioLogics GmbH & Co. KG Product
Table 217. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 218. Richter-Helm BioLogics GmbH & Co. KG Recent Development
Table 219. RoosterBio, Inc Company Details
Table 220. RoosterBio, Inc Business Overview
Table 221. RoosterBio, Inc Product
Table 222. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 223. RoosterBio, Inc Recent Development
Table 224. RoslinCT Company Details
Table 225. RoslinCT Business Overview
Table 226. RoslinCT Product
Table 227. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2015-2020) (Million US$)
Table 228. RoslinCT Recent Development
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2020 VS 2026
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026
Figure 5. Cell Defects Case Studies
Figure 6. Genetic Diseases Case Studies
Figure 7. Neurodegenerative Diseases Case Studies
Figure 8. Tissue Malignancies Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy and Tissue Engineering Report Years Considered
Figure 11. Global Cell Therapy and Tissue Engineering Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2019
Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2019
Figure 18. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Betalin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 27. BioCardia, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 29. BioReliance Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 31. Biosolution Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 33. Brainstorm Cell Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 35. MaxCyte, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 37. Medigene AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 39. MEDIPOST CO. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 41. Mesoblast Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 43. Miromatrix Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 45. MolMed S.p.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 47. Mustang Bio, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 49. NantKwest, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 51. Neuralstem, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 53. NexImmune, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 55. Nohla Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 57. ReNeuron Group plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 59. Richter-Helm BioLogics GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 61. RoosterBio, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 63. RoslinCT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Global Cell Therapy and Tissue Engineering Market Share by Type: 2020 VS 2026
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Global Cell Therapy and Tissue Engineering Market Share by Application: 2020 VS 2026
Figure 5. Cell Defects Case Studies
Figure 6. Genetic Diseases Case Studies
Figure 7. Neurodegenerative Diseases Case Studies
Figure 8. Tissue Malignancies Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy and Tissue Engineering Report Years Considered
Figure 11. Global Cell Therapy and Tissue Engineering Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell Therapy and Tissue Engineering Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell Therapy and Tissue Engineering Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Players in 2019
Figure 16. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy and Tissue Engineering as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2019
Figure 18. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell Therapy and Tissue Engineering Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Betalin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 27. BioCardia, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 29. BioReliance Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 31. Biosolution Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 33. Brainstorm Cell Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 35. MaxCyte, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 37. Medigene AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 39. MEDIPOST CO. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 41. Mesoblast Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 43. Miromatrix Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 45. MolMed S.p.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 47. Mustang Bio, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 49. NantKwest, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 51. Neuralstem, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 53. NexImmune, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 55. Nohla Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 57. ReNeuron Group plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 59. Richter-Helm BioLogics GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 61. RoosterBio, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 63. RoslinCT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
